CHLORAPREP ONE-STEP SEPP Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Chloraprep One-step Sepp, and when can generic versions of Chloraprep One-step Sepp launch?
Chloraprep One-step Sepp is a drug marketed by Becton Dickinson Co and is included in one NDA.
The generic ingredient in CHLORAPREP ONE-STEP SEPP is chlorhexidine gluconate; isopropyl alcohol. There are fifty-eight drug master file entries for this compound. Four suppliers are listed for this compound. Additional details are available on the chlorhexidine gluconate; isopropyl alcohol profile page.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for CHLORAPREP ONE-STEP SEPP?
- What are the global sales for CHLORAPREP ONE-STEP SEPP?
- What is Average Wholesale Price for CHLORAPREP ONE-STEP SEPP?
Summary for CHLORAPREP ONE-STEP SEPP
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 1 |
| Finished Product Suppliers / Packagers: | 1 |
| Raw Ingredient (Bulk) Api Vendors: | 1 |
| Clinical Trials: | 45 |
| DailyMed Link: | CHLORAPREP ONE-STEP SEPP at DailyMed |
Recent Clinical Trials for CHLORAPREP ONE-STEP SEPP
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| Yaneve Fonge | Phase 4 |
| Rush University Medical Center | N/A |
| Henry Ford Health System | Phase 4 |
Pharmacology for CHLORAPREP ONE-STEP SEPP
| Physiological Effect | Decreased Cell Wall Integrity |
US Patents and Regulatory Information for CHLORAPREP ONE-STEP SEPP
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Becton Dickinson Co | CHLORAPREP ONE-STEP SEPP | chlorhexidine gluconate; isopropyl alcohol | SWAB;TOPICAL | 021555-001 | Oct 7, 2002 | OTC | Yes | Yes | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for CHLORAPREP ONE-STEP SEPP
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
|---|---|---|---|---|---|---|---|
| Becton Dickinson Co | CHLORAPREP ONE-STEP SEPP | chlorhexidine gluconate; isopropyl alcohol | SWAB;TOPICAL | 021555-001 | Oct 7, 2002 | ⤷ Sign Up | ⤷ Sign Up |
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
International Patents for CHLORAPREP ONE-STEP SEPP
See the table below for patents covering CHLORAPREP ONE-STEP SEPP around the world.
| Country | Patent Number | Title | Estimated Expiration |
|---|---|---|---|
| European Patent Office | 0929296 | APPLICATEUR UNI-DOSE DE GLUCONATE DE CHLORHEXADINE (GCH) A DUREE DE CONSERVATION PROLONGEE (UNIT DOSE CHLORHEXADINE GLUCONATE (CHG) APPLICATOR HAVING EXTENDED CHG SHELF LIFE) | ⤷ Sign Up |
| Russian Federation | 2200532 | DOSAGE APPLICATOR OF BACTERICIDAL SUBSTANCE AND METHOD FOR ITS MANUFACTURING | ⤷ Sign Up |
| World Intellectual Property Organization (WIPO) | 9814178 | ⤷ Sign Up | |
| >Country | >Patent Number | >Title | >Estimated Expiration |
Make Better Decisions: Try a trial or see plans & pricing
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
ISSN: 2162-2639
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Major Patent Expirations 2024 - 2025
NCE-1 Patent Challenge Dates 2024 - 2025
Trigger-based marketing for the life sciences
Get DrugPatentWatch Business Intelligence Reports at Amazon.com
DrugChatter - AI-based answers to questions about drugs
RxJam - Digital Marketing for Life Sciences
Friedman, Yali. "DrugPatentWatch" DrugPatentWatch, thinkBiotech, 2024, www.DrugPatentWatch.com.
See Primary Research Papers Citing DrugPatentWatch
Follow DrugPatentWatch:
